Results 11 to 20 of about 457 (152)

A case of porokeratosis with a variety of morphological manifestations [PDF]

Clinical Case Reports
Key Clinical Message This case illustrates the clinical heterogeneity of porokeratosis (PK), with a patient presenting with both disseminated superficial actinic PK‐like facial lesions and PK of Mibelli‐like lesions on the buttocks and lower limbs ...
Xiang Zhang, Weiwei Shi, Jun Wang, Ruzhi Zhang   +3 more
doaj   +3 more sources

Successful Treatment of Refractory Disseminated Superficial Actinic Porokeratosis With Topical Ruxolitinib

Clinical Case Reports
This is the first documented case of disseminated superficial actinic porokeratosis (DSAP) successfully treated with topical ruxolitinib. The patient experienced near‐complete clearance after three months, suggesting that topical JAK inhibition may be an
Joe Khodeir, Paul Ohanian, Marielena Ohanian   +2 more
doaj   +2 more sources

Exacerbation of inflammatory disseminated superficial porokeratosis following COVID‐19 vaccination

JEADV Clinical Practice, 2023
The mRNA‐1273 vaccine for coronavirus disease (COVID‐19) authorised as one of the first COVID‐19 vaccines was released by Moderna in December 2020.
Tomomu Ishikawa, Jun Asai, Norito katoh
doaj   +2 more sources

Disseminated superficial porokeratosis with dermal amyloid deposits: A case report and review of the literature [PDF]

Journal of International Medical Research
Disseminated superficial porokeratosis with dermal amyloid deposits is exceptionally rare, with only 12 documented cases worldwide. The pathogenesis involves keratinocyte degeneration, resulting in amyloid deposition. A 76-year-old Chinese male presented
Yang Chen, Jiejie Lu, Weiwei Wu
doaj   +2 more sources

Blaschkoid disseminated superficial porokeratosis. [PDF]

BMJ Case Rep
Bhatt DM, Madke B, Khan A, Singh AL.
europepmc   +3 more sources

A Case of Refractory Giant Porokeratosis, Treated With a New Treatment Approach Consisting of Ablative CO₂ Laser and Methotrexate. [PDF]

Clin Case Rep
ABSTRACT Combined fractional CO2 laser + MTX may be an option for refractory GPK, with vigilant biopsy confirmation and malignancy surveillance.
Asilian A, Shoushtarizadeh M, Seyedyousefi S, Beheshti M, Aminjavaheri M.   +4 more
europepmc   +2 more sources

Disseminated Superficial Actinic Porokeratosis

Revista de Ciencias Médicas de Pinar del Río, 2018
Introduction: porokeratosis is a hereditary disorder of keratinization. Multiple clinical variants are described, all represented by a common primary lesion: the hyperkeratotic papule.
Adialys Acosta Rodríguez, Javier Martinez Navarro, Elizabeth Fernández López   +2 more
doaj   +1 more source

A case series of disseminated porokeratosis

Clinical Dermatology Review, 2021
Porokeratosis is an autosomal dominant disorder of epidermal keratinization resulting from abnormal expansion of latent clones following chronic ultraviolet exposure or immunosuppression.
J Logeshwari, Nippa Devi A Patel, Sirisha Varala, Ananthula Venkata Krishna   +3 more
doaj   +1 more source

Porokeratoses—A Comprehensive Review on the Genetics and Metabolomics, Imaging Methods and Management of Common Clinical Variants

Metabolites, 2023
Porokeratosis is a heterogeneous group of keratinising disorders characterised by the presence of particular microscopic structural changes, namely the presence of the cornoid lamella.
Paweł Pietkiewicz, Katarzyna Korecka, Natalia Salwowska, Ihor Kohut, Adarsha Adhikari, Monika Bowszyc-Dmochowska, Anna Pogorzelska-Antkowiak, Cristian Navarrete-Dechent   +7 more
doaj   +1 more source

Case Report: Rapid and Effective Treatment of Porokeratosis With Fractional CO₂ Laser Combined With Topical 2% Cholesterol/Lovastatin Ointment. [PDF]

J Cosmet Dermatol
Journal of Cosmetic Dermatology, Volume 24, Issue 6, June 2025.
Gao P, Zhang X, Yang H, Wang J.
europepmc   +2 more sources